secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001558370-24-000818
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics updates corporate presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Filed an updated corporate presentation slide deck on February 6, 2024.
- No specific financial results, clinical data, or strategic changes in the filing.
- Presentation likely includes general company overview and pipeline summary.
- No guidance, milestones, or forward-looking updates provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000155837024000818/0001558370-24-000818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000155837024000818/apre-20240206x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-000818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer